A patient treated with tilt training and midodrine after 68 seconds asystole during head-up tilt table testing

Fahrettin Oz1, Yaşar Cizgici, A Kaya Bilge

  • 1Istanbul University, Istanbul School of Medicine, Department of Cardiology, Istanbul, Turkey. fahrettin_oz@hotmail.com

Acta Cardiologica
|September 8, 2011
PubMed

Insights

Neurocardiogenic syncope, a common cause of fainting, can be effectively managed. This case study highlights successful treatment using midodrine and a tilt training program, preventing further fainting episodes.

Area of Science:

  • Cardiology
  • Neurology

Background:

  • Neurocardiogenic syncope is a frequent cause of syncope, often diagnosed via head-up tilt testing.
  • Recurrent episodes can significantly impact quality of life.

Observation:

  • A 21-year-old male presented with recurrent syncope, triggered by venipuncture and prolonged standing.
  • Syncope occurred during head-up tilt table testing, with sinus rhythm returning after 68 seconds.

Findings:

  • The patient received a combination therapy of midodrine (2.5 mg daily) and a structured tilt training program.
  • This therapeutic approach led to significant clinical improvement.

Implications:

  • Tilt training, combined with pharmacotherapy like midodrine, offers an effective strategy for managing recurrent neurocardiogenic syncope.
  • A six-month follow-up revealed no major adverse events, suggesting sustained therapeutic benefit.